Avasopasem

DB18481InvestigationalSmall molecule

Avasopasem: Overview.

Chemical structure of Avasopasem
Mechanism
Curator reviewed
Formula / weight
C21H35N5 · 357.546 g/mol (avg)
Also known as
(4AS,13AS,17AS,21AS)-1,2,3,4,4A,5,6,12,13,13A,14,15,16,17,17A,18,19,20,21,21A-EICOSAHYDRO-11,7-NITRILO-7H-DIBENZO(B,H)(1,4,7,10)TETRAAZACYCLOHEPTADECINE

Resolves to

Compound
UNIIHP219O4H4V
Structure
InChIKeyMTQZSJFDXWEENV-TUFLPTIASA-NSMILESC1CC[C@@H]2NCC3=CC=CC(CN[C@H]4CCCC[C@@H]4NCCN[C@H]2C1)=N3

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Avasopasem, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In